Gen-Probe Pays $53M for GTI Diagnostics

Publicly traded Gen-Probe has paid $53 million in cash for GTI Diagnostics. Gen-Probe bought the company from private equity firm the Riverside Company. GTI has operations in Milwaukee and Waukesha, Wis., and manufactures the human leukocyte antigen antibody detection products. San Diego-based Gen-Probe is a specialty diagnostics company focused on the transplantation, blood bank and specialty coagulation markets.